Delivery Order SPE2DB20D3303-SPE2DB25FA2VU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,958.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was awarded without set-aside designations through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens. This competitively awarded, firm fixed price delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order reflects the company's continued capability to compete...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens valued at $5,236.50 on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,584.22 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance to be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified pharmaceutical distributors....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,764.69 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 12, 2025, with completion targeted for August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, and represents a small-value pharmaceutical procurement within the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,184.18, with completion scheduled for August 12, 2025. This competitive award, issued without set-aside provisions, represents a firm fixed-price delivery order for the diabetes medication to support federal healthcare requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,157.59 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 19, 2025, with completion targeted for August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,508.04 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2VUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,066.90 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 21, 2025, with completion expected by August 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under the DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical prime vendor agreement extending through December 2026. The parent IDC serves as a global medical supply vehicle enabling the contractor to furnish a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare systems and the Defense Health Agency. AmerisourceBergen's consistent competitive awards for varied pharmaceutical commodities demonstrate its established capability to meet federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 8/21/25 |